Calsyntenin-2 Antibody [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # AF5480CL1
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry
Label
CoraFluor 1
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Calsyntenin-2
Ser21-Thr834 (Val366Ile)
Accession # Q9H4D0
Ser21-Thr834 (Val366Ile)
Accession # Q9H4D0
Specificity
Detects human Calsyntenin-2 in direct ELISAs. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) Calsyntenin-1 and rhCalsyntenin-3 is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for Calsyntenin-2 Antibody [CoraFluor™ 1]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: Calsyntenin-2
Alternate Names
Alcadein-gamma, Calsyntenin2, CLSTN2, CS2, CSTN2
Gene Symbol
CLSTN2
Additional Calsyntenin-2 Products
Product Documents for Calsyntenin-2 Antibody [CoraFluor™ 1]
Product Specific Notices for Calsyntenin-2 Antibody [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...